Clinical Trials in Glostrup Municipality, Denmark
39 recruiting
Showing 1–20 of 48 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Pfizer723 enrolled123 locationsNCT06641466
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Bipolar DisorderMania
Bristol-Myers Squibb424 enrolled103 locationsNCT07140913
Recruiting
Phase 2
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic AtrophyMacular Degeneration
Janssen Research & Development, LLC274 enrolled104 locationsNCT06635148
Recruiting
Phase 3
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled173 locationsNCT06929273
Recruiting
Phase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals360 enrolled106 locationsNCT06846281
Recruiting
Disease Activity Monitoring in Patients With Giant Cell Arteritis Study
Giant Cell Arteritis (GCA)
University of Aarhus175 enrolled7 locationsNCT07552636
Recruiting
Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen444 enrolled109 locationsNCT06700343
Recruiting
Phase 3
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche250 enrolled57 locationsNCT06847542
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
AbbVie488 enrolled54 locationsNCT06602479
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Merz Therapeutics GmbH780 enrolled108 locationsNCT07018713
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Merz Therapeutics GmbH990 enrolled108 locationsNCT07018700
Recruiting
Orbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell Arteritis
Giant Cell Arteritis (GCA)Ischemic Optic NeuropathyNAION - Non-Arteritic Ischemic Optic Neuropathy
Rigshospitalet, Denmark122 enrolled1 locationNCT07206238
Recruiting
Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project
Bipolar Affective DisorderSevere Mental IllnessSchizophrenia Spectrum & Other Psychotic Disorders
Bjorn H. Ebdrup75 enrolled1 locationNCT06743711
Recruiting
Phase 3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Multiple Sclerosis
Sanofi1,600 enrolled384 locationsNCT06141473
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 2
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled27 locationsNCT06627179
Recruiting
Not Applicable
Plant-Based Diet for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Center for Clinical Research and Prevention180 enrolled2 locationsNCT07268326
Recruiting
Not Applicable
Intervention to Support Partners and Informal Caregivers of Frail RA-patients
Rheumatic Arthritis
Glostrup University Hospital, Copenhagen25 enrolled1 locationNCT07442773
Recruiting
Phase 3
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
Cognitive ImpairmentSchizophrenia; Psychosis
European Group for Research In Schizophrenia171 enrolled16 locationsNCT07084831
Recruiting
Disentangling the Effect of Brain Insulin Resistance on Brain Health
Diabetes Type 2Diabetes Type 1
Henrik Bo Wiberg Larsson150 enrolled3 locationsNCT07374705